Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram

Oxidative stress and inflammation are implicated in depression. While selective serotonin reuptake inhibitors (SSRIs) like escitalopram are commonly prescribed as first-line treatments, their inconsistent efficacy and delayed onset of action necessitates the exploration of adjunctive therapies. Isorhamnetin, a flavonol, has shown antioxidant and anti-inflammatory properties that makes exploring its antidepressant effect attractive. This study aims to investigate the adjuvant potential of isorhamnetin in combination with escitalopram to enhance its antidepressant efficacy in a lipopolysaccharide (LPS)-induced depression model using Swiss albino mice. Behavioral paradigms, such as the forced swim test and open field test, were employed to assess depressive symptoms, locomotion, and sedation. Additionally, enzyme-linked immunosorbent assays were utilized to measure Nrf2, BDNF, HO-1, NO, and IL-6 levels in the prefrontal cortex and hippocampus. The results demonstrate that isorhamnetin significantly improves the antidepressant response of escitalopram, as evidenced by reduced floating time in the forced swim test. Moreover, isorhamnetin enhanced antidepressant effects of escitalopram and effectively restored depleted levels of Nrf2, BDNF, and HO-1 in the cortex caused by LPS-induced depression. Isorhamnetin shows promise in enhancing the efficacy of conventional antidepressant therapy through antioxidant and anti-inflammatory effects.

[1]  M. Ekici,et al.  Kaempferol and Isorhamnetin alleviate Lipopolysaccharide-Induced Anxiety and Depression-Like Behavioral in Balb/C Mice , 2023, Journal of the Hellenic Veterinary Medical Society.

[2]  M. Tambuwala,et al.  Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model , 2023, Nutrients.

[3]  K. Hashimoto,et al.  Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity , 2022, Cell death discovery.

[4]  A. Davey,et al.  Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice , 2022, Metabolic Brain Disease.

[5]  Yifan Xu,et al.  Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD , 2022, Frontiers in Pharmacology.

[6]  K. Hashimoto,et al.  Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents , 2021, Translational Psychiatry.

[7]  L. Fusar-Poli,et al.  Curcumin for depression: a meta-analysis , 2020, Critical reviews in food science and nutrition.

[8]  Jinfeng Zhang,et al.  Curcumin in antidepressant treatments: An overview of potential mechanisms, pre‐clinical/clinical trials and ongoing challenges , 2020, Basic & clinical pharmacology & toxicology.

[9]  Zhong-Lin Zhang,et al.  Isorhamnetin: A review of pharmacological effects. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Weisi Wang,et al.  Isorhamnetin alleviates esophageal mucosal injury in a chronic model of reflux esophagitis. , 2019, European journal of pharmacology.

[11]  N. Jamali-Raeufy,et al.  Isorhamnetin exerts neuroprotective effects in STZ-induced diabetic rats via attenuation of oxidative stress, inflammation and apoptosis , 2019, Journal of Chemical Neuroanatomy.

[12]  Yan-yan Xing,et al.  Madecassoside ameliorates lipopolysaccharide-induced neurotoxicity in rats by activating the Nrf2-HO-1 pathway , 2019, Neuroscience Letters.

[13]  A. Cuadrado,et al.  Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development , 2019, Oxidative medicine and cellular longevity.

[14]  O. Adeyemi,et al.  Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: Role of antioxidant defense, cholinergic and BDNF signaling , 2019, Brain Research.

[15]  Chunyun Li,et al.  Anti-inflammatory effects of isorhamnetin on LPS-stimulated human gingival fibroblasts by activating Nrf2 signaling pathway. , 2018, Microbial pathogenesis.

[16]  J. Choi,et al.  Anthraquinone and naphthopyrone glycosides from Cassia obtusifolia seeds mediate hepatoprotection via Nrf2-mediated HO-1 activation and MAPK modulation , 2018, Archives of Pharmacal Research.

[17]  Kai Wang,et al.  Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice , 2016, Neurochemical Research.

[18]  ZeGang Ma,et al.  Myricetin Attenuates Depressant-Like Behavior in Mice Subjected to Repeated Restraint Stress , 2015, International journal of molecular sciences.

[19]  Tao Jiang,et al.  Protective Effect of Isorhamnetin on Lipopolysaccharide-Induced Acute Lung Injury in Mice , 2015, Inflammation.

[20]  M. Pallardy,et al.  Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression , 2015, Neuroscience Letters.

[21]  Y. Yeh,et al.  Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway. , 2015, Journal of molecular and cellular cardiology.

[22]  N. Lavidis,et al.  Response of the nitrergic system to activation of the neuroendocrine stress axis , 2015, Front. Neurosci..

[23]  A. Jangra,et al.  Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. , 2014, European journal of pharmacology.

[24]  M. Bahmani,et al.  The effect of most important medicinal plants on two importnt psychiatric disorders (anxiety and depression)-a review. , 2014, Asian Pacific journal of tropical medicine.

[25]  Young Woo Kim,et al.  Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. , 2014, Toxicology and applied pharmacology.

[26]  Young Woo Kim,et al.  O-Methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activation. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  Á. Gil-Izquierdo,et al.  Phenolic compounds from Jacaranda caroba (Vell.) A. DC.: approaches to neurodegenerative disorders. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[28]  R. Kessler,et al.  The epidemiology of depression across cultures. , 2013, Annual review of public health.

[29]  R. Ho,et al.  Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. , 2012, Journal of affective disorders.

[30]  G. Wegener,et al.  Nitric Oxide Synthase Inhibitors as Antidepressants , 2010, Pharmaceuticals.

[31]  W. Jia,et al.  Common traditional Chinese medicinal herbs for dysmenorrhea , 2006, Phytotherapy research : PTR.

[32]  Jawed Alam,et al.  Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. , 2003, The Biochemical journal.

[33]  S. Kanba,et al.  Elevated plasma nitrate levels in depressive states. , 2001, Journal of affective disorders.

[34]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[35]  R. E. Graham,et al.  Open-field behavior is not related to treadmill performance in exercising rats , 1988, Physiology & Behavior.

[36]  R. Porsolt,et al.  Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.

[37]  O. Gammoh,et al.  Potential strategies to optimize the efficacy of antidepressants: Beyond the monoamine theory , 2023, Electronic Journal of General Medicine.

[38]  Yingchao Zhu,et al.  Effects of isorhamnetin on protein expression of VEGF , MMP-2 and Endostatin in Lewis lung cancer mouse , 2017 .